Navigation Links
Four of Molecular Medicine's Thought Leaders will Keynote at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference
Date:11/21/2008

Cambridge Healthtech Institute’s (CHI) flagship event, the Molecular Medicine Tri-Conference (February 24-27, 2009) will feature four of molecular medicine’s thought leaders as Plenary Keynotes.

Needham, MA (PRWEB) November 21, 2008 -— Cambridge Healthtech Institute’s (CHI) flagship event, the Molecular Medicine Tri-Conference (February 24-27, 2009) will feature four of molecular medicine’s thought leaders as Plenary Keynotes.

David Ewing Duncan, Chief Correspondent of NPR Talk’s “Biotech Nation” and best-selling Author of “Masterminds”, will offer his insights during his presentation “Brave New Age of Personalized Medicine”, scheduled Thursday, February 26, 2009 at 2:25pm.

Jay M. Tenenbaum, Ph.D, Chairman and Chief Scientist of CollabRx, Inc., will deliver a keynote presentation to discuss “Using Molecular Medicine to do Therapeutic Development in the Network Age”, on Wednesday, February 25, 2009 at 8:55am. Dr. Tenenbaum is a leader in internet commerce and tells the personal and timely story of transforming healthcare and accelerating therapy development through virtual biotechs.

Michael J. Yaszemski, M.D., Ph.D., Brigadier General of the United States Air Force Reserves and Professor of Orthopedic Surgery and Biomedical Engineering, College of Medicine, Mayo Clinic, is breaking new ground in spinal cord nerve regeneration. Dr. Yaszemski’s presentation, “Tissue Engineering Strategies for Musculoskeletal Regenerative Medicine in Civilian and Military Applications”, is on Thursday, February 26, 2009 at 7:30am.

James A. Wells, Ph.D., Professor and Chair of Pharmaceutical Chemistry, and Professor of Cellular & Molecular Pharmacology at the University of California, San Francisco is a pioneer in the hot area of fragment-based screening. Dr. Wells’ Keynote on “Engineering Cells to Death” is scheduled Thursday, February 26, 2009 at 1:40pm.
The Molecular Medicine Tri-Conference keynotes will all be held at the Moscone Convention Center in San Francisco, California.

About the Molecular Medicine Tri-Conference

The Molecular Medicine Tri-Conference is the flagship of event of CHI’s portfolio of 100+ events. Now in its sixteenth year, the Molecular Medicine Tri-Conference is the most comprehensive discovery, diagnostic and development event worldwide. For 2009, the Tri-Conference was developed around the theme of Shaping Future Medicine. Although the term ‘molecular medicine’ has been around for over 20 years, only now do researchers have the means to practice the art. Scientists now have the knowledge at their disposal to improve diagnosis and enhance the efficacy and safety of molecular therapeutics, elements that are essential for future commercial success.

The 2009 conference, you will learn to:

  • Design precision diagnostic tools and identify disease biomarkers (MOLECULAR DIAGNOSTICS)
  • Reduce late-stage attrition through translational biomarkers, more predictive models, and earlier proof-of-concept studies (TRANSLATIONAL MEDICINE)
  • Use genomic, proteomic and pathway information to identify the best drug targets (CANCER PROFILING AND PATHWAYS)
  • Optimize the design of therapeutic agents, including small- and large-molecules, (MEDICINAL CHEMISTRY, PRECLINICAL DEVELOPMENT OF BIOLOGICS)
  • Explore cell-based therapeutics, including the latest advances in stem cell therapies
  • (STEM CELL THERAPIES, PRECLINICAL DEVELOPMENT OF BIOLOGICS)
  • Map intricate pathways and identify drug intervention points
  • (CANCER PROFILING AND PATHWAYS)
  • Develop safer therapeutics that can flourish in the market with reduced chance of adverse events (PRECLINICAL DRUG SAFETY)
  • Generate effective business and diversification strategies to maximize progress with problematic targets and diseases ( EXECUTIVE SUMMIT)
  • Leverage informatics tools and strategies to improve R&D success (IT TRACK)

Last year's event had record-setting attendance that brought together 3000 delegates from over 40 countries. For questions about the Molecular Medicine Tri-Conference, call Cambridge Healthtech Institute at 781-972-5400; or visit www.Tri-Conference.com.

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

www.chicoporate.com

Press Inquiries Please Contact:
Tracey Fielding
Cambridge Healthtech Institute
Ph. (781) 972-5429

###

Read the full story at http://www.prweb.com/releases/2008/11/prweb1651694.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. A new molecular zip code, and a new drug target for Huntingtons disease
2. New knock-out gene model provides molecular clues to breast cancer
3. Molecular probe paints cancer cells in living animals, Stanford researchers find
4. Story ideas from molecular & cellular proteomics
5. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
8. Molecular profiling can accurately predict survival in colon cancer patients
9. Xceed Molecular Names Fran Tuttle to Its Board of Trustees
10. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
11. Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... DKT International, one of the ... is pleased to release their 2015 global impact data. In 2015, DKT served ... maternal deaths and 3.8 million unsafe abortions across 21 countries worldwide. , ...
(Date:5/25/2016)... ... May 25, 2016 , ... Conrad Siegel Actuaries, delivering comprehensive ... Prescription Drug survey , an employee benefits survey measuring how Central ... December 2015, indicates that employers are turning to consumer directed health care and ...
(Date:5/25/2016)... ... May 25, 2016 , ... "FCPX LUT Intense allows users to ... said Christina Austin - CEO of Pixel Film Studios. , With the FCPX ... add stylish color grades to their footage. A LUT is a Lookup Table that ...
(Date:5/25/2016)... Atlanta GA (PRWEB) , ... May 25, 2016 ... ... workplace solutions builder, has announced that it will join America's leading engineers at ... will be held at the Georgia World Congress Center. , Engineers, speakers ...
(Date:5/24/2016)... ... May 24, 2016 , ... BTC Media, ... blockchain event, Distributed: Health, to be held in Nashville, Tennessee on September 7, ... A 24-hour Hackathon preceding the event will host teams from around the world, ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... ARANZ Medical  Ltd a specialist ... has been named the Coretex Hi-Tech Emerging Company of the ... Dr Bruce Davey , CEO of ARANZ Medical says, ... good to be recognised for the work we are doing ... in 35 countries around the world from Sub-Saharan Africa through ...
(Date:5/24/2016)... , May 24, 2016 ... the world , s first dual ... fistula intervention   OrbusNeich, a global company ... expanded its portfolio to include products to treat peripheral ... the company,s first entry devices for lower limb and ...
(Date:5/24/2016)... 24, 2016 Dutch surgeons have launched a ... the world and treat patients on a global scale. Medical professionals ... Asia and the US have already signed ... and networking in a totally secure environment. Education  ... zone working together with a surgeon at Harvard to treat a ...
Breaking Medicine Technology: